Emgality Injection 120mg

Description

Emgality® (galcanezumab-gnlm) Injection 120 mg/mL – Prefilled Pen or Syringe

Product Description:
Emgality® is a prescription medication used for the preventive treatment of migraine in adults and the treatment of episodic cluster headaches. It contains galcanezumab-gnlm, a humanized monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) — a key molecule involved in migraine and cluster headache pathophysiology. Emgality helps reduce the frequency and severity of migraine attacks with convenient once-monthly dosing.

Product Features:

• Active Ingredient: Galcanezumab-gnlm

• Strength: 120 mg/mL

• Dosage Form: Single-dose, subcutaneous injection

• Presentation: Prefilled pen or prefilled syringe

• Administration:

  • Migraine Prevention: Initial loading dose of 240 mg (2 consecutive injections), followed by 120 mg once monthly

  • Episodic Cluster Headache: 300 mg once monthly at the onset of a cluster period (administered as three 100 mg injections)